Global Delirium Treatment Drugs Market Growth 2026-2032
The global Delirium Treatment Drugs market size is predicted to grow from US$ 306 million in 2025 to US$ 473 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.
United States market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Delirium Treatment Drugs players cover Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Delirium Treatment Drugs Industry Forecast? looks at past sales and reviews total world Delirium Treatment Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Delirium Treatment Drugs sales for 2026 through 2032. With Delirium Treatment Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Delirium Treatment Drugs industry.
This Insight Report provides a comprehensive analysis of the global Delirium Treatment Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Delirium Treatment Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Delirium Treatment Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Delirium Treatment Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Delirium Treatment Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Delirium Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Delirium Treatment Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Delirium Treatment Drugs players cover Mylan N.V., Pfizer Inc., Novartis AG, Gala BioPharma Ltd., Teva pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Delirium Treatment Drugs Industry Forecast? looks at past sales and reviews total world Delirium Treatment Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Delirium Treatment Drugs sales for 2026 through 2032. With Delirium Treatment Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Delirium Treatment Drugs industry.
This Insight Report provides a comprehensive analysis of the global Delirium Treatment Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Delirium Treatment Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Delirium Treatment Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Delirium Treatment Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Delirium Treatment Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Delirium Treatment Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Oral
- Injection
- Others
- Hospitals
- Clinics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Mylan N.V.
- Pfizer Inc.
- Novartis AG
- Gala BioPharma Ltd.
- Teva pharmaceuticals
- Dr Franz Kohler Chemie GmbH
- Bristol-Myers Squibb
- Regenstrief Institute Inc
- Fraser Health
- Otsuka Pharmaceutical Co. Ltd.
- Zydus Cadila
- What is the 10-year outlook for the global Delirium Treatment Drugs market?
- What factors are driving Delirium Treatment Drugs market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Delirium Treatment Drugs market opportunities vary by end market size?
- How does Delirium Treatment Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Delirium Treatment Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Delirium Treatment Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Delirium Treatment Drugs by Country/Region, 2021, 2025 & 2032
2.2 Delirium Treatment Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.2.4 Delirium Treatment Drugs Sales by Type
2.2.4.1 Global Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Delirium Treatment Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Delirium Treatment Drugs Sale Price by Type (2021-2026)
2.3 Delirium Treatment Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Delirium Treatment Drugs Sales by Application
2.3.3.1 Global Delirium Treatment Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Delirium Treatment Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Delirium Treatment Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Delirium Treatment Drugs Breakdown Data by Company
3.1.1 Global Delirium Treatment Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Delirium Treatment Drugs Sales Market Share by Company (2021-2026)
3.2 Global Delirium Treatment Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Delirium Treatment Drugs Revenue by Company (2021-2026)
3.2.2 Global Delirium Treatment Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Delirium Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Delirium Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Delirium Treatment Drugs Product Location Distribution
3.4.2 Players Delirium Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DELIRIUM TREATMENT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Delirium Treatment Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Delirium Treatment Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Delirium Treatment Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Delirium Treatment Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Delirium Treatment Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Delirium Treatment Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Delirium Treatment Drugs Sales Growth
4.4 APAC Delirium Treatment Drugs Sales Growth
4.5 Europe Delirium Treatment Drugs Sales Growth
4.6 Middle East & Africa Delirium Treatment Drugs Sales Growth
5 AMERICAS
5.1 Americas Delirium Treatment Drugs Sales by Country
5.1.1 Americas Delirium Treatment Drugs Sales by Country (2021-2026)
5.1.2 Americas Delirium Treatment Drugs Revenue by Country (2021-2026)
5.2 Americas Delirium Treatment Drugs Sales by Type (2021-2026)
5.3 Americas Delirium Treatment Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Delirium Treatment Drugs Sales by Region
6.1.1 APAC Delirium Treatment Drugs Sales by Region (2021-2026)
6.1.2 APAC Delirium Treatment Drugs Revenue by Region (2021-2026)
6.2 APAC Delirium Treatment Drugs Sales by Type (2021-2026)
6.3 APAC Delirium Treatment Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Delirium Treatment Drugs by Country
7.1.1 Europe Delirium Treatment Drugs Sales by Country (2021-2026)
7.1.2 Europe Delirium Treatment Drugs Revenue by Country (2021-2026)
7.2 Europe Delirium Treatment Drugs Sales by Type (2021-2026)
7.3 Europe Delirium Treatment Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Delirium Treatment Drugs by Country
8.1.1 Middle East & Africa Delirium Treatment Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Delirium Treatment Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Delirium Treatment Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Delirium Treatment Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Delirium Treatment Drugs
10.3 Manufacturing Process Analysis of Delirium Treatment Drugs
10.4 Industry Chain Structure of Delirium Treatment Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Delirium Treatment Drugs Distributors
11.3 Delirium Treatment Drugs Customer
12 WORLD FORECAST REVIEW FOR DELIRIUM TREATMENT DRUGS BY GEOGRAPHIC REGION
12.1 Global Delirium Treatment Drugs Market Size Forecast by Region
12.1.1 Global Delirium Treatment Drugs Forecast by Region (2027-2032)
12.1.2 Global Delirium Treatment Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Delirium Treatment Drugs Forecast by Type (2027-2032)
12.7 Global Delirium Treatment Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mylan N.V.
13.1.1 Mylan N.V. Company Information
13.1.2 Mylan N.V. Delirium Treatment Drugs Product Portfolios and Specifications
13.1.3 Mylan N.V. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mylan N.V. Main Business Overview
13.1.5 Mylan N.V. Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Delirium Treatment Drugs Product Portfolios and Specifications
13.2.3 Pfizer Inc. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Delirium Treatment Drugs Product Portfolios and Specifications
13.3.3 Novartis AG Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Gala BioPharma Ltd.
13.4.1 Gala BioPharma Ltd. Company Information
13.4.2 Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
13.4.3 Gala BioPharma Ltd. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Gala BioPharma Ltd. Main Business Overview
13.4.5 Gala BioPharma Ltd. Latest Developments
13.5 Teva pharmaceuticals
13.5.1 Teva pharmaceuticals Company Information
13.5.2 Teva pharmaceuticals Delirium Treatment Drugs Product Portfolios and Specifications
13.5.3 Teva pharmaceuticals Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva pharmaceuticals Main Business Overview
13.5.5 Teva pharmaceuticals Latest Developments
13.6 Dr Franz Kohler Chemie GmbH
13.6.1 Dr Franz Kohler Chemie GmbH Company Information
13.6.2 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolios and Specifications
13.6.3 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr Franz Kohler Chemie GmbH Main Business Overview
13.6.5 Dr Franz Kohler Chemie GmbH Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Regenstrief Institute Inc
13.8.1 Regenstrief Institute Inc Company Information
13.8.2 Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolios and Specifications
13.8.3 Regenstrief Institute Inc Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regenstrief Institute Inc Main Business Overview
13.8.5 Regenstrief Institute Inc Latest Developments
13.9 Fraser Health
13.9.1 Fraser Health Company Information
13.9.2 Fraser Health Delirium Treatment Drugs Product Portfolios and Specifications
13.9.3 Fraser Health Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Fraser Health Main Business Overview
13.9.5 Fraser Health Latest Developments
13.10 Otsuka Pharmaceutical Co. Ltd.
13.10.1 Otsuka Pharmaceutical Co. Ltd. Company Information
13.10.2 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
13.10.3 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Otsuka Pharmaceutical Co. Ltd. Main Business Overview
13.10.5 Otsuka Pharmaceutical Co. Ltd. Latest Developments
13.11 Zydus Cadila
13.11.1 Zydus Cadila Company Information
13.11.2 Zydus Cadila Delirium Treatment Drugs Product Portfolios and Specifications
13.11.3 Zydus Cadila Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zydus Cadila Main Business Overview
13.11.5 Zydus Cadila Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Delirium Treatment Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Delirium Treatment Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Delirium Treatment Drugs by Country/Region, 2021, 2025 & 2032
2.2 Delirium Treatment Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 Others
2.2.4 Delirium Treatment Drugs Sales by Type
2.2.4.1 Global Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Delirium Treatment Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Delirium Treatment Drugs Sale Price by Type (2021-2026)
2.3 Delirium Treatment Drugs Segment by Application
2.3.1 Hospitals
2.3.2 Clinics
2.3.3 Delirium Treatment Drugs Sales by Application
2.3.3.1 Global Delirium Treatment Drugs Sale Market Share by Application (2021-2026)
2.3.3.2 Global Delirium Treatment Drugs Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Delirium Treatment Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Delirium Treatment Drugs Breakdown Data by Company
3.1.1 Global Delirium Treatment Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Delirium Treatment Drugs Sales Market Share by Company (2021-2026)
3.2 Global Delirium Treatment Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Delirium Treatment Drugs Revenue by Company (2021-2026)
3.2.2 Global Delirium Treatment Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Delirium Treatment Drugs Sale Price by Company
3.4 Key Manufacturers Delirium Treatment Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Delirium Treatment Drugs Product Location Distribution
3.4.2 Players Delirium Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DELIRIUM TREATMENT DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Delirium Treatment Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Delirium Treatment Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Delirium Treatment Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Delirium Treatment Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Delirium Treatment Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Delirium Treatment Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Delirium Treatment Drugs Sales Growth
4.4 APAC Delirium Treatment Drugs Sales Growth
4.5 Europe Delirium Treatment Drugs Sales Growth
4.6 Middle East & Africa Delirium Treatment Drugs Sales Growth
5 AMERICAS
5.1 Americas Delirium Treatment Drugs Sales by Country
5.1.1 Americas Delirium Treatment Drugs Sales by Country (2021-2026)
5.1.2 Americas Delirium Treatment Drugs Revenue by Country (2021-2026)
5.2 Americas Delirium Treatment Drugs Sales by Type (2021-2026)
5.3 Americas Delirium Treatment Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Delirium Treatment Drugs Sales by Region
6.1.1 APAC Delirium Treatment Drugs Sales by Region (2021-2026)
6.1.2 APAC Delirium Treatment Drugs Revenue by Region (2021-2026)
6.2 APAC Delirium Treatment Drugs Sales by Type (2021-2026)
6.3 APAC Delirium Treatment Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Delirium Treatment Drugs by Country
7.1.1 Europe Delirium Treatment Drugs Sales by Country (2021-2026)
7.1.2 Europe Delirium Treatment Drugs Revenue by Country (2021-2026)
7.2 Europe Delirium Treatment Drugs Sales by Type (2021-2026)
7.3 Europe Delirium Treatment Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Delirium Treatment Drugs by Country
8.1.1 Middle East & Africa Delirium Treatment Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Delirium Treatment Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Delirium Treatment Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Delirium Treatment Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Delirium Treatment Drugs
10.3 Manufacturing Process Analysis of Delirium Treatment Drugs
10.4 Industry Chain Structure of Delirium Treatment Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Delirium Treatment Drugs Distributors
11.3 Delirium Treatment Drugs Customer
12 WORLD FORECAST REVIEW FOR DELIRIUM TREATMENT DRUGS BY GEOGRAPHIC REGION
12.1 Global Delirium Treatment Drugs Market Size Forecast by Region
12.1.1 Global Delirium Treatment Drugs Forecast by Region (2027-2032)
12.1.2 Global Delirium Treatment Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Delirium Treatment Drugs Forecast by Type (2027-2032)
12.7 Global Delirium Treatment Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Mylan N.V.
13.1.1 Mylan N.V. Company Information
13.1.2 Mylan N.V. Delirium Treatment Drugs Product Portfolios and Specifications
13.1.3 Mylan N.V. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Mylan N.V. Main Business Overview
13.1.5 Mylan N.V. Latest Developments
13.2 Pfizer Inc.
13.2.1 Pfizer Inc. Company Information
13.2.2 Pfizer Inc. Delirium Treatment Drugs Product Portfolios and Specifications
13.2.3 Pfizer Inc. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Inc. Main Business Overview
13.2.5 Pfizer Inc. Latest Developments
13.3 Novartis AG
13.3.1 Novartis AG Company Information
13.3.2 Novartis AG Delirium Treatment Drugs Product Portfolios and Specifications
13.3.3 Novartis AG Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Novartis AG Main Business Overview
13.3.5 Novartis AG Latest Developments
13.4 Gala BioPharma Ltd.
13.4.1 Gala BioPharma Ltd. Company Information
13.4.2 Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
13.4.3 Gala BioPharma Ltd. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Gala BioPharma Ltd. Main Business Overview
13.4.5 Gala BioPharma Ltd. Latest Developments
13.5 Teva pharmaceuticals
13.5.1 Teva pharmaceuticals Company Information
13.5.2 Teva pharmaceuticals Delirium Treatment Drugs Product Portfolios and Specifications
13.5.3 Teva pharmaceuticals Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Teva pharmaceuticals Main Business Overview
13.5.5 Teva pharmaceuticals Latest Developments
13.6 Dr Franz Kohler Chemie GmbH
13.6.1 Dr Franz Kohler Chemie GmbH Company Information
13.6.2 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolios and Specifications
13.6.3 Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Dr Franz Kohler Chemie GmbH Main Business Overview
13.6.5 Dr Franz Kohler Chemie GmbH Latest Developments
13.7 Bristol-Myers Squibb
13.7.1 Bristol-Myers Squibb Company Information
13.7.2 Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolios and Specifications
13.7.3 Bristol-Myers Squibb Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Bristol-Myers Squibb Main Business Overview
13.7.5 Bristol-Myers Squibb Latest Developments
13.8 Regenstrief Institute Inc
13.8.1 Regenstrief Institute Inc Company Information
13.8.2 Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolios and Specifications
13.8.3 Regenstrief Institute Inc Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Regenstrief Institute Inc Main Business Overview
13.8.5 Regenstrief Institute Inc Latest Developments
13.9 Fraser Health
13.9.1 Fraser Health Company Information
13.9.2 Fraser Health Delirium Treatment Drugs Product Portfolios and Specifications
13.9.3 Fraser Health Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Fraser Health Main Business Overview
13.9.5 Fraser Health Latest Developments
13.10 Otsuka Pharmaceutical Co. Ltd.
13.10.1 Otsuka Pharmaceutical Co. Ltd. Company Information
13.10.2 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
13.10.3 Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Otsuka Pharmaceutical Co. Ltd. Main Business Overview
13.10.5 Otsuka Pharmaceutical Co. Ltd. Latest Developments
13.11 Zydus Cadila
13.11.1 Zydus Cadila Company Information
13.11.2 Zydus Cadila Delirium Treatment Drugs Product Portfolios and Specifications
13.11.3 Zydus Cadila Delirium Treatment Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Zydus Cadila Main Business Overview
13.11.5 Zydus Cadila Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Delirium Treatment Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Delirium Treatment Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Others
Table 6. Global Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Delirium Treatment Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Delirium Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Delirium Treatment Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Delirium Treatment Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Delirium Treatment Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Delirium Treatment Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Delirium Treatment Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Delirium Treatment Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Delirium Treatment Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Delirium Treatment Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Delirium Treatment Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Delirium Treatment Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Delirium Treatment Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Delirium Treatment Drugs Producing Area Distribution and Sales Area
Table 22. Players Delirium Treatment Drugs Products Offered
Table 23. Delirium Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Delirium Treatment Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Delirium Treatment Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Delirium Treatment Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Delirium Treatment Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Delirium Treatment Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Delirium Treatment Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Delirium Treatment Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Delirium Treatment Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Delirium Treatment Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Delirium Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Delirium Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Delirium Treatment Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Delirium Treatment Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Delirium Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Delirium Treatment Drugs
Table 53. Key Market Challenges & Risks of Delirium Treatment Drugs
Table 54. Key Industry Trends of Delirium Treatment Drugs
Table 55. Delirium Treatment Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Delirium Treatment Drugs Distributors List
Table 58. Delirium Treatment Drugs Customer List
Table 59. Global Delirium Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Delirium Treatment Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Delirium Treatment Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Delirium Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Delirium Treatment Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Delirium Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Delirium Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Delirium Treatment Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Delirium Treatment Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Delirium Treatment Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Delirium Treatment Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Mylan N.V. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Mylan N.V. Delirium Treatment Drugs Product Portfolios and Specifications
Table 75. Mylan N.V. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Mylan N.V. Main Business
Table 77. Mylan N.V. Latest Developments
Table 78. Pfizer Inc. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Inc. Delirium Treatment Drugs Product Portfolios and Specifications
Table 80. Pfizer Inc. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Pfizer Inc. Main Business
Table 82. Pfizer Inc. Latest Developments
Table 83. Novartis AG Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis AG Delirium Treatment Drugs Product Portfolios and Specifications
Table 85. Novartis AG Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novartis AG Main Business
Table 87. Novartis AG Latest Developments
Table 88. Gala BioPharma Ltd. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
Table 90. Gala BioPharma Ltd. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Gala BioPharma Ltd. Main Business
Table 92. Gala BioPharma Ltd. Latest Developments
Table 93. Teva pharmaceuticals Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva pharmaceuticals Delirium Treatment Drugs Product Portfolios and Specifications
Table 95. Teva pharmaceuticals Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Teva pharmaceuticals Main Business
Table 97. Teva pharmaceuticals Latest Developments
Table 98. Dr Franz Kohler Chemie GmbH Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolios and Specifications
Table 100. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Dr Franz Kohler Chemie GmbH Main Business
Table 102. Dr Franz Kohler Chemie GmbH Latest Developments
Table 103. Bristol-Myers Squibb Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolios and Specifications
Table 105. Bristol-Myers Squibb Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Regenstrief Institute Inc Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolios and Specifications
Table 110. Regenstrief Institute Inc Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Regenstrief Institute Inc Main Business
Table 112. Regenstrief Institute Inc Latest Developments
Table 113. Fraser Health Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Fraser Health Delirium Treatment Drugs Product Portfolios and Specifications
Table 115. Fraser Health Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Fraser Health Main Business
Table 117. Fraser Health Latest Developments
Table 118. Otsuka Pharmaceutical Co. Ltd. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
Table 120. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Otsuka Pharmaceutical Co. Ltd. Main Business
Table 122. Otsuka Pharmaceutical Co. Ltd. Latest Developments
Table 123. Zydus Cadila Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Cadila Delirium Treatment Drugs Product Portfolios and Specifications
Table 125. Zydus Cadila Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zydus Cadila Main Business
Table 127. Zydus Cadila Latest Developments
Table 1. Delirium Treatment Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Delirium Treatment Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Major Players of Others
Table 6. Global Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Delirium Treatment Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Delirium Treatment Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Delirium Treatment Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Delirium Treatment Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Delirium Treatment Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Delirium Treatment Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Delirium Treatment Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Delirium Treatment Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Delirium Treatment Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Delirium Treatment Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Delirium Treatment Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Delirium Treatment Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Delirium Treatment Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Delirium Treatment Drugs Producing Area Distribution and Sales Area
Table 22. Players Delirium Treatment Drugs Products Offered
Table 23. Delirium Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Delirium Treatment Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Delirium Treatment Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Delirium Treatment Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Delirium Treatment Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Delirium Treatment Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Delirium Treatment Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Delirium Treatment Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Delirium Treatment Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Delirium Treatment Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Delirium Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Delirium Treatment Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Delirium Treatment Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Delirium Treatment Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Delirium Treatment Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Delirium Treatment Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Delirium Treatment Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Delirium Treatment Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Delirium Treatment Drugs
Table 53. Key Market Challenges & Risks of Delirium Treatment Drugs
Table 54. Key Industry Trends of Delirium Treatment Drugs
Table 55. Delirium Treatment Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Delirium Treatment Drugs Distributors List
Table 58. Delirium Treatment Drugs Customer List
Table 59. Global Delirium Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Delirium Treatment Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Delirium Treatment Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Delirium Treatment Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Delirium Treatment Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Delirium Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Delirium Treatment Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Delirium Treatment Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Delirium Treatment Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Delirium Treatment Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Delirium Treatment Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Delirium Treatment Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Mylan N.V. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Mylan N.V. Delirium Treatment Drugs Product Portfolios and Specifications
Table 75. Mylan N.V. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Mylan N.V. Main Business
Table 77. Mylan N.V. Latest Developments
Table 78. Pfizer Inc. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Pfizer Inc. Delirium Treatment Drugs Product Portfolios and Specifications
Table 80. Pfizer Inc. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Pfizer Inc. Main Business
Table 82. Pfizer Inc. Latest Developments
Table 83. Novartis AG Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Novartis AG Delirium Treatment Drugs Product Portfolios and Specifications
Table 85. Novartis AG Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Novartis AG Main Business
Table 87. Novartis AG Latest Developments
Table 88. Gala BioPharma Ltd. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Gala BioPharma Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
Table 90. Gala BioPharma Ltd. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Gala BioPharma Ltd. Main Business
Table 92. Gala BioPharma Ltd. Latest Developments
Table 93. Teva pharmaceuticals Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva pharmaceuticals Delirium Treatment Drugs Product Portfolios and Specifications
Table 95. Teva pharmaceuticals Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Teva pharmaceuticals Main Business
Table 97. Teva pharmaceuticals Latest Developments
Table 98. Dr Franz Kohler Chemie GmbH Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Product Portfolios and Specifications
Table 100. Dr Franz Kohler Chemie GmbH Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Dr Franz Kohler Chemie GmbH Main Business
Table 102. Dr Franz Kohler Chemie GmbH Latest Developments
Table 103. Bristol-Myers Squibb Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Bristol-Myers Squibb Delirium Treatment Drugs Product Portfolios and Specifications
Table 105. Bristol-Myers Squibb Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Bristol-Myers Squibb Main Business
Table 107. Bristol-Myers Squibb Latest Developments
Table 108. Regenstrief Institute Inc Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Regenstrief Institute Inc Delirium Treatment Drugs Product Portfolios and Specifications
Table 110. Regenstrief Institute Inc Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Regenstrief Institute Inc Main Business
Table 112. Regenstrief Institute Inc Latest Developments
Table 113. Fraser Health Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Fraser Health Delirium Treatment Drugs Product Portfolios and Specifications
Table 115. Fraser Health Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Fraser Health Main Business
Table 117. Fraser Health Latest Developments
Table 118. Otsuka Pharmaceutical Co. Ltd. Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Product Portfolios and Specifications
Table 120. Otsuka Pharmaceutical Co. Ltd. Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Otsuka Pharmaceutical Co. Ltd. Main Business
Table 122. Otsuka Pharmaceutical Co. Ltd. Latest Developments
Table 123. Zydus Cadila Basic Information, Delirium Treatment Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Zydus Cadila Delirium Treatment Drugs Product Portfolios and Specifications
Table 125. Zydus Cadila Delirium Treatment Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Zydus Cadila Main Business
Table 127. Zydus Cadila Latest Developments
LIST OF FIGURES
Figure 1. Picture of Delirium Treatment Drugs
Figure 2. Delirium Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Delirium Treatment Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Delirium Treatment Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Delirium Treatment Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Delirium Treatment Drugs Sales Market Share by Country/Region (2025)
Figure 10. Delirium Treatment Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Product Picture of Others
Figure 14. Global Delirium Treatment Drugs Sales Market Share by Type in 2026
Figure 15. Global Delirium Treatment Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Delirium Treatment Drugs Consumed in Hospitals
Figure 17. Global Delirium Treatment Drugs Market: Hospitals (2021-2026) & (K Units)
Figure 18. Delirium Treatment Drugs Consumed in Clinics
Figure 19. Global Delirium Treatment Drugs Market: Clinics (2021-2026) & (K Units)
Figure 20. Global Delirium Treatment Drugs Sale Market Share by Application (2025)
Figure 21. Global Delirium Treatment Drugs Revenue Market Share by Application in 2026
Figure 22. Delirium Treatment Drugs Sales by Company in 2026 (K Units)
Figure 23. Global Delirium Treatment Drugs Sales Market Share by Company in 2026
Figure 24. Delirium Treatment Drugs Revenue by Company in 2026 ($ millions)
Figure 25. Global Delirium Treatment Drugs Revenue Market Share by Company in 2026
Figure 26. Global Delirium Treatment Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Delirium Treatment Drugs Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 29. Americas Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 30. APAC Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 31. APAC Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 32. Europe Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 33. Europe Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 36. Americas Delirium Treatment Drugs Sales Market Share by Country in 2026
Figure 37. Americas Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 38. Americas Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 39. Americas Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 40. United States Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Delirium Treatment Drugs Sales Market Share by Region in 2026
Figure 45. APAC Delirium Treatment Drugs Revenue Market Share by Region (2021-2026)
Figure 46. APAC Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 47. APAC Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 48. China Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. India Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Delirium Treatment Drugs Sales Market Share by Country in 2026
Figure 56. Europe Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 57. Europe Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 58. Europe Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 59. Germany Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. France Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 67. Egypt Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Delirium Treatment Drugs in 2026
Figure 73. Manufacturing Process Analysis of Delirium Treatment Drugs
Figure 74. Industry Chain Structure of Delirium Treatment Drugs
Figure 75. Channels of Distribution
Figure 76. Global Delirium Treatment Drugs Sales Market Forecast by Region (2027-2032)
Figure 77. Global Delirium Treatment Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Delirium Treatment Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Delirium Treatment Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Delirium Treatment Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Delirium Treatment Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Delirium Treatment Drugs
Figure 2. Delirium Treatment Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Delirium Treatment Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Delirium Treatment Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Delirium Treatment Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Delirium Treatment Drugs Sales Market Share by Country/Region (2025)
Figure 10. Delirium Treatment Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Oral
Figure 12. Product Picture of Injection
Figure 13. Product Picture of Others
Figure 14. Global Delirium Treatment Drugs Sales Market Share by Type in 2026
Figure 15. Global Delirium Treatment Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Delirium Treatment Drugs Consumed in Hospitals
Figure 17. Global Delirium Treatment Drugs Market: Hospitals (2021-2026) & (K Units)
Figure 18. Delirium Treatment Drugs Consumed in Clinics
Figure 19. Global Delirium Treatment Drugs Market: Clinics (2021-2026) & (K Units)
Figure 20. Global Delirium Treatment Drugs Sale Market Share by Application (2025)
Figure 21. Global Delirium Treatment Drugs Revenue Market Share by Application in 2026
Figure 22. Delirium Treatment Drugs Sales by Company in 2026 (K Units)
Figure 23. Global Delirium Treatment Drugs Sales Market Share by Company in 2026
Figure 24. Delirium Treatment Drugs Revenue by Company in 2026 ($ millions)
Figure 25. Global Delirium Treatment Drugs Revenue Market Share by Company in 2026
Figure 26. Global Delirium Treatment Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 27. Global Delirium Treatment Drugs Revenue Market Share by Geographic Region in 2026
Figure 28. Americas Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 29. Americas Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 30. APAC Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 31. APAC Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 32. Europe Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 33. Europe Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 34. Middle East & Africa Delirium Treatment Drugs Sales 2021-2026 (K Units)
Figure 35. Middle East & Africa Delirium Treatment Drugs Revenue 2021-2026 ($ millions)
Figure 36. Americas Delirium Treatment Drugs Sales Market Share by Country in 2026
Figure 37. Americas Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 38. Americas Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 39. Americas Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 40. United States Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 41. Canada Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 42. Mexico Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 43. Brazil Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. APAC Delirium Treatment Drugs Sales Market Share by Region in 2026
Figure 45. APAC Delirium Treatment Drugs Revenue Market Share by Region (2021-2026)
Figure 46. APAC Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 47. APAC Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 48. China Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 49. Japan Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 50. South Korea Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 51. Southeast Asia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. India Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Australia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. China Taiwan Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Europe Delirium Treatment Drugs Sales Market Share by Country in 2026
Figure 56. Europe Delirium Treatment Drugs Revenue Market Share by Country (2021-2026)
Figure 57. Europe Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 58. Europe Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 59. Germany Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 60. France Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 61. UK Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 62. Italy Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. Russia Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Country (2021-2026)
Figure 65. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Type (2021-2026)
Figure 66. Middle East & Africa Delirium Treatment Drugs Sales Market Share by Application (2021-2026)
Figure 67. Egypt Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. South Africa Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 69. Israel Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 70. Turkey Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. GCC Countries Delirium Treatment Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Delirium Treatment Drugs in 2026
Figure 73. Manufacturing Process Analysis of Delirium Treatment Drugs
Figure 74. Industry Chain Structure of Delirium Treatment Drugs
Figure 75. Channels of Distribution
Figure 76. Global Delirium Treatment Drugs Sales Market Forecast by Region (2027-2032)
Figure 77. Global Delirium Treatment Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 78. Global Delirium Treatment Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 79. Global Delirium Treatment Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 80. Global Delirium Treatment Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 81. Global Delirium Treatment Drugs Revenue Market Share Forecast by Application (2027-2032)
